Local Storage seems to be disabled in your browser.
For the best experience on our site, be sure to turn on Local Storage in your browser.
Proteq West Nile 2x1 dose
Proteq West Nile 2x1 dose + syringe
Suspension for injection containing West Nile recombinant canarypox virus (vCP2017).
The vaccine strain vCP2017 is a recombinant canarypox virus expressing the preM/E genes of West Nile virus. After inoculation, the virus does not multiply in the horse but expresses the protective proteins. As a consequence, these proteins induce protective immunity against equine West Nile disease.
Active immunisation of horses from 5 months of age against West Nile disease. Proteq West Nile reduces the number of viraemic horses. If clinical signs are present, their duration and severity are reduced.
Onset of immunity: 4 weeks after the first dose of the primary vaccination course. In order to achieve full protection, the full vaccination course of two doses must be given.
Duration of immunity: 1 year after a full primary vaccination course of two injections.
Route of administation and dosage
For intramuscular use.
Shake gently before use.
Administer one dose of 1ml, by intramuscular injection, preferably in the neck region, according to the following schedule:
- Primary vaccination course: first injection from 5 months of age, second injection 4-6 weeks later
- Revaccination: a sufficient degree of protection should be achieved after an annual booster injection with a single dose although this schedule has not been fully validated.
|Registration number||REG NL 107618|
|Active Ingredient||West Nile recombinant canarypox virus|
|Legal status of supply||UDD|
|Withdrawal period||0 days|
|Expiry date||Sep 4, 2022|
|Units per outer box||0|